GENOMIC HEALTH, INC.
CIK 0001131324
Revenue (TTM)
$357.55M
+3.3% YoY
Q3 Oct 2019
Net Income (TTM)
$59.91M
−27.1% YoY
Q3 Oct 2019
EPS Diluted (TTM)
$1.56
−28.1% YoY
Q3 Oct 2019
Gross Margin
80.7%
Q3 Oct 2019
Operating Margin
16.2%
Q3 Oct 2019
Net Margin
16.8%
Q3 Oct 2019
Free Cash Flow (TTM)
$60.89M
Q3 Oct 2019
Cash
$71.96M
Q3 Oct 2019
Total Debt
—
Q3 Oct 2019
Shares Outstanding
37.59M sh
Q3 Oct 2019